Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 16, 2018Research and Practice in Thrombosis and HaemostasisOpen Access

Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPaul CoppoDélégation Paris 5ACAdam CukerBrigham and Women's HospitalJGJames N. GeorgeUniversity of Oklahoma Health Sciences Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Coppo et al. (2018) studied this question.

synapsesocial.com/papers/6a82931d1d8eddfbf50f654bhttps://doi.org/10.1002/rth2.12160
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 20152017 · 302 citations
  2. 2N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice2011 · 244 citations
  3. 3Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura2017 · 73 citations
  4. 4Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers2018 · 46 citations
  5. 5Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience2012 · 160 citations